2MZW
 
 | | Staphylococcus aureus FusB:EF-GC3 complex | | Descriptor: | Elongation factor G, Far1, ZINC ION | | Authors: | Tomlinson, J.H, Thompson, G.S, Kalverda, A.P, Zhuravleva, A, O'Neill, A. | | Deposit date: | 2015-02-25 | | Release date: | 2016-01-27 | | Last modified: | 2024-05-15 | | Method: | SOLUTION NMR | | Cite: | A target-protection mechanism of antibiotic resistance at atomic resolution: insights into FusB-type fusidic acid resistance.
Sci Rep, 6, 2016
|
|
9GZP
 | | WT-IAPP cryo-EM structure Type LL - control reaction | | Descriptor: | Islet amyloid polypeptide | | Authors: | Wilkinson, M, Taylor, A.I.P, Xu, Y, Chakraborty, P, Brinkworth, A, Willis, L.F, Zhuravleva, A, Ranson, N.A, Foster, R, Radford, S.E. | | Deposit date: | 2024-10-04 | | Release date: | 2025-03-05 | | Last modified: | 2025-04-16 | | Method: | ELECTRON MICROSCOPY (2.9 Å) | | Cite: | Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug.
J.Am.Chem.Soc., 147, 2025
|
|
9GZY
 | | WT-IAPP cryo-EM structure Type LLUU, doxazosin reaction | | Descriptor: | Islet amyloid polypeptide | | Authors: | Wilkinson, M, Taylor, A.I.P, Xu, Y, Chakraborty, P, Brinkworth, A, Willis, L.F, Zhuravleva, A, Ranson, N.A, Foster, R, Radford, S.E. | | Deposit date: | 2024-10-04 | | Release date: | 2025-03-05 | | Last modified: | 2025-04-16 | | Method: | ELECTRON MICROSCOPY (3 Å) | | Cite: | Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug.
J.Am.Chem.Soc., 147, 2025
|
|
9GZW
 | | WT-IAPP cryo-EM structure Type LL, doxazosin reaction | | Descriptor: | Islet amyloid polypeptide | | Authors: | Wilkinson, M, Taylor, A.I.P, Xu, Y, Chakraborty, P, Brinkworth, A, Willis, L.F, Zhuravleva, A, Ranson, N.A, Foster, R, Radford, S.E. | | Deposit date: | 2024-10-04 | | Release date: | 2025-03-05 | | Last modified: | 2025-04-16 | | Method: | ELECTRON MICROSCOPY (2.9 Å) | | Cite: | Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug.
J.Am.Chem.Soc., 147, 2025
|
|
9GZ6
 | | WT-IAPP cryo-EM structure Type SS - control reaction | | Descriptor: | Islet amyloid polypeptide | | Authors: | Wilkinson, M, Taylor, A.I.P, Xu, Y, Chakraborty, P, Brinkworth, A, Willis, L.F, Zhuravleva, A, Ranson, N.A, Foster, R, Radford, S.E. | | Deposit date: | 2024-10-03 | | Release date: | 2025-03-05 | | Last modified: | 2025-04-16 | | Method: | ELECTRON MICROSCOPY (3.3 Å) | | Cite: | Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug.
J.Am.Chem.Soc., 147, 2025
|
|
9GZS
 | | WT-IAPP cryo-EM structure Type LLU - control reaction | | Descriptor: | Islet amyloid polypeptide | | Authors: | Wilkinson, M, Taylor, A.I.P, Xu, Y, Chakraborty, P, Brinkworth, A, Willis, L.F, Zhuravleva, A, Ranson, N.A, Foster, R, Radford, S.E. | | Deposit date: | 2024-10-04 | | Release date: | 2025-03-05 | | Last modified: | 2025-04-16 | | Method: | ELECTRON MICROSCOPY (3.1 Å) | | Cite: | Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug.
J.Am.Chem.Soc., 147, 2025
|
|
9GZT
 | | WT-IAPP cryo-EM structure Type LLUU - control reaction | | Descriptor: | Islet amyloid polypeptide | | Authors: | Wilkinson, M, Taylor, A.I.P, Xu, Y, Chakraborty, P, Brinkworth, A, Willis, L.F, Zhuravleva, A, Ranson, N.A, Foster, R, Radford, S.E. | | Deposit date: | 2024-10-04 | | Release date: | 2025-03-05 | | Last modified: | 2025-04-16 | | Method: | ELECTRON MICROSCOPY (2.9 Å) | | Cite: | Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug.
J.Am.Chem.Soc., 147, 2025
|
|
9GZX
 | | WT-IAPP cryo-EM structure Type LLU, doxazosin reaction | | Descriptor: | Islet amyloid polypeptide | | Authors: | Wilkinson, M, Taylor, A.I.P, Xu, Y, Chakraborty, P, Brinkworth, A, Willis, L.F, Zhuravleva, A, Ranson, N.A, Foster, R, Radford, S.E. | | Deposit date: | 2024-10-04 | | Release date: | 2025-03-05 | | Last modified: | 2025-04-16 | | Method: | ELECTRON MICROSCOPY (3.1 Å) | | Cite: | Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug.
J.Am.Chem.Soc., 147, 2025
|
|
6FHK
 | |
